Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Gabapentin NDC 45963-556 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

1 - image 1

1 - image 1

The given text is a formula used to estimate the Glomerular Filtration Rate (GFR) for a patient. GFR is a measure of how well the kidneys are functioning. The formula calculates cLcr (creatinine clearance) value using the patient's age, weight, and serum creatinine level (which indicates how much creatinine is in their blood, another measure of kidney function). This formula is commonly used in clinical settings to monitor and assess kidney function in patients.*

1 - image 10

1 - image 10

1 - image 11

1 - image 11

1 - image 12

1 - image 12

1 - image 13

1 - image 13

Gabapentin is a drug that comes in the form of capsules containing USP-indicated amounts of the active ingredient. The packaging includes a warning to keep this medication out of children's reach and to store it at a certain temperature. Patients are instructed to consult the accompanying circular for full dosing information. Additionally, the pharmacist should dispense the medication guide along with the drug. The medication is produced in India by Watson Pharma Private Limited, on behalf of Teva Pharmaceuticals in Parsippany, NJ. Details on serialization and lot/expiry dates are also provided.*

1 - image 14

1 - image 14

Gabapentin Capsules, USP is a prescription medication available in the form of capsules. Each capsule contains 300mg Gabapentin, USP. It is manufactured by Watson Pharma Private Limited in India and is distributed by Teva Pharmaceuticals in Parsippany, NJ. The medication should be stored in a tight, light-resistant container as defined by the USP and kept out of children's reach. A medication guide should be provided to the patient with each prescription. The dosage details can be found in the accompanying circular for full prescribing information. For any questions, call 1-888-838-2872. Lot/exp and serialization coding area details are also provided.*

1 - image 15

1 - image 15

This text describes a medication in the form of capsules with the active ingredient Gabapentin. It instructs pharmacists to dispense a Medication Guide to each patient and to keep the capsules in a tightly closed and light-resistant container. The usual dosage is detailed in an accompanying circular. The medication should be kept out of the reach of children and stored between 20° to 25°C. The medication was manufactured in India by Watson Pharma Private Limited and is distributed by Teva Pharmaceuticals. The text includes lot and expiration dates, a serialization coding area, and a contact number for questions.*

1 - image 2

1 - image 2

1 - image 3

1 - image 3

1 - image 4

1 - image 4

1 - image 5

1 - image 5

1 - image 6

1 - image 6

The text describes a chart showing the mean pain score for a study that has a dose titration period followed by a fixed dose period of 4 weeks. The study compares the effects of a placebo versus Gabapentin administered at a maximum dose of 3600 mg/day. The chart shows the mean pain score at baseline and over the course of the 4 weeks.*

2 - image 7

2 - image 7

This text includes information about a study that evaluated the effectiveness of Gabapentin in reducing pain. The study involved a fixed dose period of four weeks, during which participants were given either 1800mg or 2400mg of Gabapentin. The mean pain score was recorded and showed a value of zero. There is also information about the duration of the treatment period, which included both a titration period and a fixed dose period.*

3 - image 8

3 - image 8

4 - image 9

4 - image 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.